The Global 2024 Tuberculosis Report further indicates that at least 8 million people, 500, 000 more than the number in 2022, ...

The treatment was successful in 89 per cent of the people with drug-susceptible TB; 73 per cent of those with an infection ...

India has achieved over 80% TB treatment coverage in 2023, despite the high cost and long duration of therapy. The country ...

The WHO's latest report on tuberculosis shows that it's once again the leading cause of death from a single infectious ...

Tuberculosis is again the leading cause of deaths from infectious disease after COVID-19 displaced it briefly during the ...

One of the main challenges of contemporary medicine is posed by the resistance of pathogens to antibiotics. An important step ...

In the highest tally ever recorded for tuberculosis cases, the World Health Organization reported Tuesday that over ...

The World Health Organization (WHO) today published a new report on tuberculosis revealing that approximately 8.2 million people were newly diagnosed with TB in 2023 – the highest number recorded ...

One of the main challenges of contemporary medicine is posed by the resistance of pathogens to antibiotics. An important step in countering it has now been made by researchers from IOCB Prague, in ...

The National Institutes of Health has identified several CYP3A4 inducers, including "barbiturates (phenobarbital), carbamazepine, corticosteroids, phenytoin, rifampicin and St John's wort." ...

tuberculosis complex that is resistant to rifampicin and isoniazid. The treatment success rate for people diagnosed with MDR/RR-TB has steadily improved but remains alarmingly low. Nwokafor and others ...

It is produced for easy nasal delivery. These can hold TB drugs like isoniazid (INH) and rifampicin (RIF). “By delivering the drug through the nasal route, the nano-aggregates can transport the drugs ...